Completed PHASE4 INTERVENTIONAL 2-arm NCT00421863

Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

Sponsor: Heart Care Foundation

Interventions Catapresan TTS 2 Lasix 25 Micardis 80 mg Micardis plus 80/12.5 Norvasc 10 mg Pluscor Triatec 10 mg Triatec 5 mg Triatec HCT 5

Updated 7 times since 2017 Last updated: Feb 2, 2021 Started: Feb 28, 2005 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension and is currently completed. Heart Care Foundation leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Mar 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heart Care Foundation

Data source: Heart Care Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aosta, Italy , Benevento, Italy , Brescia, Italy , Cagliari, Italy , Caltanissetta, Italy , Casarano, Italy , Castiglione del Lago, Italy , Catania, Italy , Catanzaro, Italy , Chiari, Italy and 30 more locations